<DOC>
	<DOCNO>NCT02099149</DOCNO>
	<brief_summary>Compare anticapsular antibody level Group B Streptococcus delivery mother infant develop disease versus . Use comparison establish antibody level associate reduction risk GBS disease infant age less 90 day .</brief_summary>
	<brief_title>Antibody Levels Associated With Reduced Risk Invasive Group B Streptococcus Disease Infants Aged Less Than 90 Days</brief_title>
	<detailed_description />
	<mesh_term>Antibodies</mesh_term>
	<criteria>Pregnant woman attend participate community/hospital antenatal clinic and/or deliver participate delivery center . Subjects age â‰¥18 year . Able understand comply plan study procedure . Provides write informed consent . Refuses consent study participation .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Group B Streptococcus</keyword>
	<keyword>early onset disease</keyword>
	<keyword>late onset disease</keyword>
	<keyword>anticapsular antibody</keyword>
	<keyword>serotype specific</keyword>
</DOC>